Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
266.69M | 262.08M | 251.43M | 223.93M | 165.09M | 197.85M | Gross Profit |
33.42M | 31.70M | 33.58M | 31.95M | 22.78M | 25.00M | EBIT |
4.09M | 1.18M | 4.50M | 5.67M | 2.89M | 1.67M | EBITDA |
5.80M | 3.06M | 6.75M | 7.32M | 4.68M | 3.29M | Net Income Common Stockholders |
1.29M | -1.20M | 2.52M | 3.00M | 1.41M | -252.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.74M | 438.00K | 4.23M | 2.76M | 5.74M | 1.48M | Total Assets |
98.10M | 99.54M | 100.03M | 84.49M | 94.82M | 94.54M | Total Debt |
14.69M | 34.99M | 32.77M | 26.41M | 38.44M | 44.30M | Net Debt |
11.95M | 34.55M | 28.54M | 23.65M | 32.70M | 42.82M | Total Liabilities |
67.44M | 70.81M | 68.37M | 49.76M | 67.23M | 68.16M | Stockholders Equity |
30.66M | 28.74M | 31.66M | 34.73M | 27.59M | 26.38M |
Cash Flow | Free Cash Flow | ||||
1.09M | -2.46M | 3.33M | 553.00K | 6.33M | -1.78M | Operating Cash Flow |
3.03M | 119.00K | 4.24M | 3.39M | 6.72M | -802.00K | Investing Cash Flow |
-1.75M | -2.33M | -716.00K | -2.65M | -209.00K | -980.00K | Financing Cash Flow |
-1.75M | -1.57M | -2.05M | -3.71M | -2.26M | -648.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £2.57B | 6.69 | 18.69% | 6.55% | -19.08% | 57.32% | |
74 Outperform | £5.97B | 31.67 | 256.58% | 1.58% | 7.02% | -0.37% | |
70 Outperform | £205.71M | 11.86 | 5.09% | 2.77% | 7.94% | -25.81% | |
69 Neutral | £692.12M | 22.43 | 4.76% | 3.93% | -7.75% | 66.58% | |
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
55 Neutral | £12.27M | ― | 7.69% | ― | ― |